oxybutynin has been researched along with Apoplexy in 9 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In men with hypogonadism and preexisting or a high risk of cardiovascular disease, testosterone-replacement therapy was noninferior to placebo with respect to the incidence of major adverse cardiac events." | 3.30 | Cardiovascular Safety of Testosterone-Replacement Therapy. ( Basaria, S; Bhasin, S; Boden, WE; Chan, A; Cunningham, GR; Davey, D; Dubcenco, E; Flevaris, P; Granger, CB; Huang, B; Kalahasti, V; Khan, N; Khera, M; Li, X; Lincoff, AM; Miller, MG; Mitchell, LM; Nissen, SE; Pencina, KM; Snabes, MC; Thompson, IM; Travison, TG; Wang, Q; Wolski, K; Yi, T, 2023) |
| "Infections were associated with an increased risk of death (p < 0." | 2.84 | Infections Up to 76 Days After Stroke Increase Disability and Death. ( Bath, PM; Bereczki, D; Berge, E; Caso, V; Christensen, H; Collins, R; Czlonkowska, A; El Etribi, A; Farr, TD; Fone, KC; Gommans, J; Laska, AC; Learoyd, AE; Ntaios, G; Ozturk, S; Pocock, SJ; Prasad, K; Shaw, L; Sprigg, N; Trueman, RC; Wardlaw, JM; Woodhouse, L, 2017) |
| "High blood pressure is a common complication in acute stroke and is associated with a poor outcome." | 2.76 | The effect of transdermal glyceryl trinitrate on 24 h ambulatory blood pressure in acute/subacute stroke. ( Bath, AJ; Bath, PM; Geeganage, CM, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 3 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Lincoff, AM | 1 |
| Bhasin, S | 1 |
| Flevaris, P | 1 |
| Mitchell, LM | 1 |
| Basaria, S | 1 |
| Boden, WE | 1 |
| Cunningham, GR | 1 |
| Granger, CB | 1 |
| Khera, M | 1 |
| Thompson, IM | 1 |
| Wang, Q | 1 |
| Wolski, K | 1 |
| Davey, D | 1 |
| Kalahasti, V | 1 |
| Khan, N | 1 |
| Miller, MG | 1 |
| Snabes, MC | 1 |
| Chan, A | 1 |
| Dubcenco, E | 1 |
| Li, X | 1 |
| Yi, T | 1 |
| Huang, B | 1 |
| Pencina, KM | 1 |
| Travison, TG | 1 |
| Nissen, SE | 1 |
| Appleton, JP | 2 |
| Krishnan, K | 1 |
| Bath, PM | 4 |
| Iwano, T | 1 |
| Toda, H | 1 |
| Nakamura, K | 1 |
| Shimizu, K | 1 |
| Ejiri, K | 1 |
| Naito, Y | 1 |
| Mori, H | 1 |
| Masuda, T | 1 |
| Miyoshi, T | 1 |
| Yoshida, M | 1 |
| Hikasa, Y | 1 |
| Morimatsu, H | 1 |
| Ito, H | 1 |
| Learoyd, AE | 1 |
| Woodhouse, L | 1 |
| Shaw, L | 1 |
| Sprigg, N | 2 |
| Bereczki, D | 1 |
| Berge, E | 1 |
| Caso, V | 1 |
| Christensen, H | 1 |
| Collins, R | 1 |
| Czlonkowska, A | 1 |
| El Etribi, A | 1 |
| Farr, TD | 1 |
| Gommans, J | 1 |
| Laska, AC | 1 |
| Ntaios, G | 1 |
| Ozturk, S | 1 |
| Pocock, SJ | 1 |
| Prasad, K | 1 |
| Wardlaw, JM | 1 |
| Fone, KC | 1 |
| Trueman, RC | 1 |
| Marchitto, N | 1 |
| Sindona, F | 1 |
| Pannozzi, A | 1 |
| Dalmaso, SG | 1 |
| Anticoli, S | 1 |
| Raimondi, G | 1 |
| Mohammed, K | 1 |
| Abu Dabrh, AM | 1 |
| Benkhadra, K | 1 |
| Al Nofal, A | 1 |
| Carranza Leon, BG | 1 |
| Prokop, LJ | 1 |
| Montori, VM | 1 |
| Faubion, SS | 1 |
| Murad, MH | 1 |
| Brown, S | 1 |
| Geeganage, CM | 1 |
| Bath, AJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Prospective, Collaborative, International, Multicentre, Randomised, Parallel-group, Single and Outcome Blinded, Controlled, Factorial Trial to Investigate the Safety and Efficacy of Treatment With Transdermal Glyceryl Trinitrate, a Nitric Oxide Donor, a[NCT00989716] | Phase 3 | 3,500 participants (Anticipated) | Interventional | 2001-07-31 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for oxybutynin and Apoplexy
| Article | Year |
|---|---|
Transdermal delivery of glyceryl trinitrate: clinical applications in acute stroke.
Topics: Administration, Cutaneous; Hemodynamics; Humans; Nitric Oxide Donors; Nitroglycerin; Quality of Life | 2020 |
Oral vs Transdermal Estrogen Therapy and Vascular Events: A Systematic Review and Meta-Analysis.
Topics: Administration, Oral; Estrogen Replacement Therapy; Evidence-Based Medicine; Female; Humans; Menopau | 2015 |
Therapeutic Potential of Transdermal Glyceryl Trinitrate in the Management of Acute Stroke.
Topics: Administration, Cutaneous; Blood Pressure; Cerebrovascular Circulation; Humans; Nitric Oxide Donors; | 2017 |
4 trials available for oxybutynin and Apoplexy
| Article | Year |
|---|---|
Cardiovascular Safety of Testosterone-Replacement Therapy.
Topics: Aged; Aged, 80 and over; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Double-Blind Method; Ge | 2023 |
Preventative effects of bisoprolol transdermal patches on postoperative atrial fibrillation in high-risk patients undergoing non-cardiac surgery: A subanalysis of the MAMACARI study.
Topics: Aged; Atrial Fibrillation; Bisoprolol; Humans; Postoperative Complications; Risk Factors; Stroke; Tr | 2021 |
Infections Up to 76 Days After Stroke Increase Disability and Death.
Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Incidence; Infections; Male; Middle Aged; Nitroglyce | 2017 |
The effect of transdermal glyceryl trinitrate on 24 h ambulatory blood pressure in acute/subacute stroke.
Topics: Aged; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Female; Humans; Hypertension; Male; Nit | 2011 |
2 other studies available for oxybutynin and Apoplexy
| Article | Year |
|---|---|
Safety and efficacy of Rotigotine in hospedalized patients with Vascular Parkinsonism aged 75 and older: effects on movement, praxis capacities, time-space orientation, quality of life and adherence to medical therapy.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Brain Ischemia; Cognition; Dopamine Agonists; Fe | 2019 |
Transdermal hormone replacement therapy not associated with an increased risk of stroke.
Topics: Aged; Case-Control Studies; Female; Hormone Replacement Therapy; Humans; Longitudinal Studies; Meta- | 2010 |